The second mechanism is associated with platelet activation via the TLR4-MyD88-cGMP-protein kinase G (PKG) pathway, which exacerbated platelet aggregation and caused thrombocytopenia in response to injection of LPS [77]. The gene discussed is TLR4; the disease is Thrombocytopenia.